Peterson Amy C.

Avg. Two Year Performance

No purchase track record
(115%) Avg. Sale Return
(47%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(10%)(3%)(< 1%)(42%)(115%)
Sale Success Rate1 of 41 of 42 of 41 of 40 of 4
Drugs » Biotechnology

EVP Prod Dev & Med Aff & CMO:

Holdings: 322.12K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

EVP, Chief Development Officer:

Holdings: 58.43K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

CMO, Immuno-oncology:

Holdings: 194.57K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--